114 Results for "

ATR

" in MedChemExpress (MCE) Product Catalog:
Products (114)

114 Results for "ATR" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
  • Recombinant Proteins Recommended:
68
68 Publications Verification
Cat. No.: HY-19323
CAS No.: 1352226-88-0
Synonyms: AZD6738
Target:  

ATM/ATR

Research Areas:  

Cancer

Ceralasertib (AZD6738) is an orally active and bioavailable inhibitor of ATR kinase with an IC50 of 1 nM.
loading...
    loading...
66
66 Cited Publications
Cat. No.: HY-12016
CAS No.: 587871-26-9
Purity:  99.92%
Target:  

ATM/ATR Autophagy

Research Areas:  

Cancer

KU-55933 is a potent ATM inhibitor with an IC50 and Ki of 12.9 and 2.2 nM, respectively, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.
loading...
    loading...
55
55 Cited Publications
Cat. No.: HY-14731
CAS No.: 1232410-49-9
Purity:  99.67%
Target:  

ATM/ATR

Research Areas:  

Cancer

VE-821 is a potent ATP-competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-13902
CAS No.: 1232416-25-9
Purity:  99.70%
Synonyms: VE-822; VX-970; M6620
Research Areas:  

Infection Metabolic Disease Cancer

Berzosertib (VE-822) is an orally active, CNS-penetrant, and selective ATR kinase inhibitor. Berzosertib blocks ATR kinase activity, abrogates G2/M cell cycle checkpoint, impairs DNA damage repair. Berzosertib induces apoptosis, inhibnits conlony migration, inhibits cell proliferation, and activates cGAS-STING axes in cancer cells. Berzosertib can be used for the research of cancers, such as head and neck squamous cell carcinoma, and colorectal cancer .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-13902A
CAS No.: 1428935-04-9
Synonyms: VE-822 hydrochloride; VX-970 hydrochloride; M6620 hydrochloride
Research Areas:  

Neurological Disease Cancer

Berzosertib (VE-822) hydrochloride is an orally active, CNS-penetrant, and selective ATR kinase inhibitor. Berzosertib hydrochloride blocks ATR kinase activity, abrogates G2/M cell cycle checkpoint, impairs DNA damage repair. Berzosertib hydrochloride induces apoptosis, inhibnits conlony migration, inhibits cell proliferation, and activates cGAS-STING axes in cancer cells. Berzosertib hydrochloride can be used for the research of cancers, such as head and neck squamous cell carcinoma, and colorectal cancer .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-B0097
CAS No.: 50-91-9
Synonyms: 5-Fluorouracil 2'-deoxyriboside
Floxuridine (5-Fluorouracil 2'-deoxyriboside) is a pyrimidine analog and known as an oncology antimetabolite. Floxuridine inhibits Poly(ADP-Ribose) polymerase and induces DNA damage by activating the ATM and ATR checkpoint signaling pathways in vitro. Floxuridine is a extreamly potent inhibitor for S. aureus infection and induces cell apoptosis . Floxuridine has antiviral effects against HSV and CMV .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-101566
CAS No.: 1876467-74-1
Purity:  99.99%
Synonyms: BAY 1895344
Target:  

ATM/ATR

Research Areas:  

Cancer

Elimusertib (BAY-1895344) is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib has anti-tumor activity . Elimusertib can be used for the research of solid tumors and lymphomas .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-101566A
Purity:  99.85%
Synonyms: BAY 1895344 hydrochloride
Target:  

ATM/ATR

Research Areas:  

Cancer

Elimusertib (BAY 1895344) hydrochloride is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib hydrochloride has anti-tumor activity . Elimusertib hydrochloride can be used for the research of solid tumors and lymphomas .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-15557
CAS No.: 1233339-22-4
Purity:  99.40%
Target:  

ATM/ATR

Research Areas:  

Cancer

AZ20 is a potent and selective inhibitor of ATR with an IC50 of 5 nM, and has 8-fold selectivity against mTOR (IC50=38 nM).
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-15520
CAS No.: 905973-89-9
Purity:  99.83%
Target:  

ATM/ATR

Research Areas:  

Cancer

CGK733 is a potent ATM/ATR inhibitor, used for the research of cancer.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-136270
CAS No.: 1613191-99-3
Purity:  99.77%
Synonyms: VX-803; M4344; ATR inhibitor 2
Target:  

ATM/ATR

Research Areas:  

Cancer

Gartisertib (VX-803) is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. Gartisertib potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-16705
CAS No.: 1374601-40-7
Research Areas:  

Cancer

BRD4770 is a histone methyltransferase G9a inhibitor. BRD4770 reduces di- and trimethylation of lysine 9 on histone H3 (H3K9) with an EC50 of 5 μM, and has less or little effect toward H3K27me3, H3K36me3, H3K4me3, and H3K79me3. BRD4770 can activate the ataxia telangiectasia mutated (ATM) pathway and induce cell senescence .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100399
CAS No.: 133825-80-6
Synonyms: PD-132301; ATR-101
Research Areas:  

Cancer

Nevanimibe (PD-132301) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe induces cell apoptosis and has the potential for adrenocortical cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100399A
CAS No.: 133825-81-7
Purity:  99.49%
Synonyms: PD-132301 hydrochloride; ATR101 hydrochloride
Research Areas:  

Cancer

Nevanimibe hydrochloride (PD-132301 hydrochloride) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe hydrochloride inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe hydrochloride induces cell apoptosis and has the potential for adrenocortical cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-139609
CAS No.: 2417489-10-0
Purity:  99.75%
Synonyms: RP-3500; ATR inhibitor 4
Target:  

ATM/ATR mTOR

Research Areas:  

Cancer

Camonsertib (RP-3500) is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. Camonsertib shows 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases. Camonsertib has potent antitumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15521
CAS No.: 1345675-02-6
Purity:  99.54%
Target:  

mTOR ATM/ATR

Research Areas:  

Cancer

ETP-46464 is an effective mTOR and ATR inhibitor with IC50s of 0.6 and 14 nM, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-150617
CAS No.: 2495096-26-7
Purity:  99.94%
Synonyms: M4076; ATM Inhibitor-5
Lartesertib (M4076) is an inhibitor of the serine/threonine protein kinase ATM with high potency. Lartesertib can inhibit the growth of multiple hematopoietic cell lines. Additionally, when combined with the ATR inhibitor Tuvusertib (HY-111451), Lartesertib can promote the death of tumor cells, activate the immune signaling pathway, and exhibit anti-tumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19323A
CAS No.: 1352226-87-9
Synonyms: (S)-AZD6738
Target:  

ATM/ATR

Research Areas:  

Cancer

(S)-Ceralasertib ((S)-AZD6738) is the S-enantiomer of Ceralasertib (HY-19323). (S)-Ceralasertib is the inhibitor for ataxia telangiectasia mutated and rad3 related (ATR) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0255
CAS No.: 142340-99-6
Synonyms: GS 0840
Adefovir dipivoxil is an orally active adenosine analog and Adefovir prodrug. Adefovir dipivoxil inhibits DNA synthesis, activates the ATR signaling pathway, and disrupts the KCTD12-CDK1 interaction. Adefovir dipivoxil has antiviral activity against PRV, HBV, and orthopoxviruses. Adefovir dipivoxil has inhibitory effects on both lamivudine-resistant and wild-type strains. Adefovir dipivoxil has antitumor activity against lung and colon cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N6954
CAS No.: 76996-27-5
Garcinone C, a xanthone derivative, is a natural compound extracted from Garcinia oblongifolia that is used as an anti-inflammatory, astringency and granulation-promoting medicine, and has potential cytotoxic effects on certain cancers. Garcinone C stimulates the expression levels of ATR and 4E-BP1, arrests the cell cycle, inhibits cell viability of the human Nasopharyngeal carcinoma (NPC) cell lines CNE1, CNE2, HK1 and HONE1 in a time‑ and dose‑dependent manner through inhibition of Hedgehog signaling pathway. Garcinone C is orally active .
loading...
    loading...